Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

What Excites You Most About the Life Sciences Industry in 2021?

Posted on February 19th, 2021 by

Pharma R&D

We have looked back at some of the biggest advances in 2020, but it’s a new year and time to look ahead, so we asked our Life Sciences team what they are looking forward to in 2021.

(more…)

How to Use Reaxys Reaction Data to Create Chemistry Models

Posted on February 11th, 2021 by

Chemistry

These days, a chemist’s digital tools are as valued as the physical ones, and those digital tools are enabling chemists to do some amazing things in the lab. One example is predictive reaction chemistry, a thriving area with a rapidly-developing variety of algorithms and approaches.   

(more…)

What Were the Biggest Advances in Life Sciences in 2020?

Posted on February 8th, 2021 by

Pharma R&D

As we settle into a new year, it’s always good to take a moment to consider what was accomplished in the previous one. That’s why we asked members of Elsevier’s Life Sciences team what they felt were among the most noteworthy advances in the life sciences in 2020.

(more…)

Workforce Upskilling in Pharma R&D

Posted on February 5th, 2021 by

Pharma R&D

There is comfort in habits. There is comfort in the familiar. In normal times, change usually only occurs at a relatively slow pace. When we update one of our cell phone applications, it usually takes a while before we adopt this new fancy functionality and take advantage of it. After all, it has been working well for us even before the update, right? So why change if things are fine? Even in our work, we find comfort in routines and repeating tasks that we feel we are good at. But there are changes that we cannot hide from.

(more…)

Future of Pharma and RELX Reports Highlight Importance of Tech

Posted on January 29th, 2021 by

Pharma R&D

Innovation in pharmaceutical R&D is inextricably tied to technological advancement. Two recently-released reports further highlight how much success in pharma is now being driven by groundbreaking tech.

(more…)

Elsevier to Work with Heel for Mechanism-based Drug Action Discovery

Posted on January 6th, 2021 by

Pharma R&D

Elsevier, the data analytics business specialized in science and health, and Heel, a pharmaceutical company specialized in developing and manufacturing medicines made from natural ingredients, have recently completed a series of research projects with a focus on improving exploratory preclinical studies.

(more…)

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. …
  7. 83

About this Blog

iStock_000019748868_Full

The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.

Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier,  its affiliates and sponsors or its parent company, Reed Elsevier.